Reference interval for the C-ACT activated clotting time test in healthy dogs using a water bath and manual assessment of clot formation

References

• Abdullah WZ, Moufak SK, Yusof Z, Mohamad MS, Kamarul IM. Shortened activated partial thromboplastin time, a hemostatic marker for hypercoagulable state during acute coronary event. Translational Research 155, 315–9, 2010. https://doi.org/10.1016/j.trsl.2010.02.001
   PubMed Web of Science ®Google Scholar
• *Atkins LB. Blood sample collection and handling. In: Burkitt Creedon JM, Davis H (eds). Advanced Monitoring and Procedures for Small Animal Emergency and Critical Care. 1st Edtn. Pp 601–10. Wiley Blackwell, Ames, IA, USA, 2012
   Google Scholar
• Bonett DG, Wright TA. Sample size requirements for estimating Pearson, Kendall and Spearman correlations. Psychometrika 65, 23–8, 2000
   Web of Science ®Google Scholar
• Byars TD, Ling G, Ferris NA, Keeton KS. Activated coagulation time (ACT) of whole blood in normal dogs. American Journal of Veterinary Research 37, 1359–61, 1976
   PubMed Web of Science ®Google Scholar
• Casado-Méndez M, Fernandez-Pacheco J, Arellano-Orden V, Rodríguez-Martorell FJ, Díaz-Martín A, Pastor de las Heras Á, Dusseck-Brutus R, Pérez-Torres I, Leal-Noval SR. Relationship of thromboelastography and conventional clotting test values with severe bleeding in critically ill patients with coagulopathy: a prospective study. International Journal of Laboratory Hematology 41, 671–8, 2019. https://doi.org/10.1111/ijlh.13086
   PubMed Web of Science ®Google Scholar
• Dirkmann D, Nagy E, Britten MW, Peters J. Point-of-care measurement of activated clotting time for cardiac surgery as measured by the Hemochron signature elite and the Abbott i-STAT: agreement, concordance, and clinical reliability. BMC Anesthesiology 19, 174, 2019. https://doi.org/10.1186/s12871-019-0846-z
   PubMed Web of Science ®Google Scholar
• FitzGerald D, Patel A, Body S, Garvin S. The relationship between heparin level and activated clotting time in the adult cardiac surgery population. Perfusion 24, 93–6, 2009. https://doi.org/10.1177/0267659109106729
   PubMed Web of Science ®Google Scholar
• Friedrichs KR, Harr KE, Freeman KP, Szladovits B, Walton RM, Barnhart KF, Blanco-Chavez J. ASVCP reference interval guidelines: determination of de novo reference intervals in veterinary species and other related topics. Veterinary Clinical Pathology 41, 441–53, 2012. https://doi.org/10.1111/vcp.12006
   PubMed Web of Science ®Google Scholar
• Glaus T, Hudak-Glaus D, Hoeptner C, Arnold P, Lutz H. The activated coagulation time (ACT): two simple screening tests for evaluating coagulation disorders in dogs. Schweizer Archiv Fur Tierheilkunde 138, 532–6, 1996
   PubMed Web of Science ®Google Scholar
• Haas T, Spielmann N, Mauch J, Schmugge M, Weiss M. Correlation of activated clotting times and standard laboratory coagulation tests in paediatric non-cardiac surgery. Scandinavian Journal of Clinical and Laboratory Investigation 73, 29–33, 2013. https://doi.org/10.3109/00365513.2012.732239
   PubMed Web of Science ®Google Scholar
• Hattersley PG. Activated coagulation time of whole blood. Journal of the American Medical Association 196, 436–40, 1966. https://doi.org/10.1001/jama.1966.03100180108036
   PubMed Web of Science ®Google Scholar
• Huyzen RJ, van Oeveren W, Wei F, Stellingwerf P, Boonstra PW, Gu YJ. In vitro effect of hemodilution on activated clotting time and high-dose thrombin time during cardiopulmonary bypass. The Annals of Thoracic Surgery 62, 533–7, 1996. https://doi.org/10.1016/0003-4975(96)00324-4
   PubMed Web of Science ®Google Scholar
• Larsen JB, Hvas AM. Predictive value of whole blood and plasma coagulation tests for intra- and postoperative bleeding risk: a systematic review. Seminars in Thrombosis and Hemostasis 43, 772–805, 2017. https://doi.org/10.1055/s-0037-1602665
   PubMed Web of Science ®Google Scholar
• *Lubas G, Caldin M, Wiinberg B, Kristensen AT. Laboratory testing of coagulation disorders. In: Weiss DJ, Wardrop KJ, Schalm OW (eds). Schalm‘s Veterinary Hematology. 6th Edtn. Pp 1082–100. Wiley Blackwell, Ames, IA, USA, 2010
   Google Scholar
• Maslow A, Chambers A, Chevees T, Sweeney J. Assessment of heparin anticoagulation measured using i-STAT and hemochron activated clotting time. Journal of Cardiothoracic and Vascular Anesthesia 32, 1603–8, 2018. https://doi.org/10.1053/j.jvca.2018.01.027
   PubMed Web of Science ®Google Scholar
• Middleton DJ, Watson ADJ. Activated coagulation times of whole blood in normal dogs and dogs with coagulopathies. Journal of Small Animal Practice 19, 417–22, 1978. https://doi.org/10.1111/j.1748-5827.1978.tb05516.x
   PubMed Web of Science ®Google Scholar
• Mina A, Favaloro EJ, Koutts J. Relationship between short activated partial thromboplastin times, thrombin generation, procoagulant factors and procoagulant phospholipid activity. Blood Coagulation & Fibrinolysis 23, 203–7, 2012. https://doi.org/10.1097/MBC.0b013e32834fa7d6
   PubMed Web of Science ®Google Scholar
• Mina A, Favaloro EJ, Mohammed S, Koutts J. A laboratory evaluation into the short activated partial thromboplastin time. Blood Coagulation & Fibrinolysis 21, 152–7, 2010. https://doi.org/10.1097/MBC.0b013e3283365770
   PubMed Web of Science ®Google Scholar
• *Schultze AE. Interpretation of canine leukocyte responses. In: Weiss DJ, Wardrop KJ, Schalm OW (eds). Schalm‘s Veterinary Hematology. 6th Edtn. Pp 321–34. Wiley Blackwell, Ames, IA, USA, 2010
   Google Scholar
• See AM, Swindells KL, Sharman MJ, Haack KL, Goodman D, Delaporta A, Robertson I, Foster SF. Activated coagulation times in normal cats and dogs using MAX-ACT TM tubes. Australian Veterinary Journal 87, 292–5, 2009. https://doi.org/10.1111/j.1751-0813.2009.00450.x
   PubMed Web of Science ®Google Scholar
• Segal JB, Dzik WH. Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review. Transfusion 45, 1413–25, 2005. https://doi.org/10.1111/j.1537-2995.2005.00546.x
   PubMed Web of Science ®Google Scholar
• Shiel RE, Brennan SF, O’Rourke LG, McCullough M, Mooney CT. Hematologic values in young pretraining healthy Greyhounds. Veterinary Clinical Pathology 36, 274–7, 2007. https://doi.org/10.1111/j.1939-165X.2007.tb00223.x
   PubMed Web of Science ®Google Scholar
• Smythe MA, Koerber JM, Nowak SN, Mattson JC, Begle RL, Westley SJ, Balasubramaniam M. Correlation between activated clotting time and activated partial thromboplastin times. Annals of Pharmacotherapy 36, 7–11, 2002. https://doi.org/10.1345/aph.1A141
   PubMed Web of Science ®Google Scholar
• Song J, Drobatz KJ, Silverstein DC. Retrospective evaluation of shortened prothrombin time or activated partial thromboplastin time for the diagnosis of hypercoagulability in dogs: 25 cases (2006–2011). Journal of Veterinary Emergency and Critical Care 26, 398–405, 2016. https://doi.org/10.1111/vec.12478
   PubMed Web of Science ®Google Scholar
• Thenappan T, Swamy R, Shah A, Nathan S, Nichols J, Bond L, Jolly N. Interchangeability of activated clotting time values across different point-of-care systems. The American Journal of Cardiology 109, 1379–82, 2012. https://doi.org/10.1016/j.amjcard.2011.12.033
   PubMed Web of Science ®Google Scholar
• *Topper MJ, Welles EG. Hemostasis. In: Latimer KS, Mahaffey EA, Prasse KW (eds). Duncan & Prasse’s Veterinary Laboratory Medicine: Clinical Pathology. 4th Edtn. Pp 99–135. Iowa State Press, Ames, IA, USA, 2003
   Google Scholar
• Zaldívar-López S, Marín LM, Iazbik MC, Westendorf-Stingle N, Hensley S, Couto CG. Clinical pathology of Greyhounds and other sighthounds. Veterinary Clinical Pathology 40, 414–25, 2011. https://doi.org/10.1111/j.1939-165X.2011.00360.x
   PubMed Web of Science ®Google Scholar
• *Non-peer-reviewed
   Google Scholar